NervGen Pharma (TSE:NGEN) has released an update. NervGen Pharma, a clinical-stage biotech company, is set to present at the Stifel 2024 ...

Vancouver, British Columbia--(Newsfile Corp. - November 7, 2024) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQB: NGENF), a ...

Enhance your stock picks with dividend metrics like per-share dividends, yield, frequency, payout ratios, and more.

In the last year, drugmakers have talked up the prospect of medicines discovered or designed by artificial intelligence. AI could accelerate the pace of new drugs approved to treat everything from ...

Drugmaker Mayne Pharma Group, which has lost 59 per cent of its share market value over the past five years, is giving some thought to life away from the ASX boards. Pubs baron Bruce Mathieson at ...

The 80's and 90's spawned a host of selling models and most of us in the pharma business have been trained to use one or multiple different selling models. However, how many pharma executives ...

Representatives of Targovax interviewed by pharmaphorum said the marketplace is set to get increasingly crowded in the future as pharma tries to use the approach to improve efficacy of checkpoint ...

PRWeek’s UK Power Book reveals the PR pros who lead the way in their respective sectors. Today, we rank the key in-house players in healthcare and pharma comms. PRWeek’s UK Power Book reveals the PR ...

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech. Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive ...